Your browser doesn't support javascript.
loading
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Callendret, Benoit; Vellinga, Jort; Wunderlich, Kerstin; Rodriguez, Ariane; Steigerwald, Robin; Dirmeier, Ulrike; Cheminay, Cedric; Volkmann, Ariane; Brasel, Trevor; Carrion, Ricardo; Giavedoni, Luis D; Patterson, Jean L; Mire, Chad E; Geisbert, Thomas W; Hooper, Jay W; Weijtens, Mo; Hartkoorn-Pasma, Jutta; Custers, Jerome; Grazia Pau, Maria; Schuitemaker, Hanneke; Zahn, Roland.
Afiliação
  • Callendret B; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Vellinga J; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Wunderlich K; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Rodriguez A; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Steigerwald R; Bavarian Nordic GmbH, Martinsried, Germany.
  • Dirmeier U; Bavarian Nordic GmbH, Martinsried, Germany.
  • Cheminay C; Bavarian Nordic GmbH, Martinsried, Germany.
  • Volkmann A; Bavarian Nordic GmbH, Martinsried, Germany.
  • Brasel T; University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Carrion R; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Giavedoni LD; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Patterson JL; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Mire CE; University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Geisbert TW; University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Hooper JW; Virology Division, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
  • Weijtens M; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Hartkoorn-Pasma J; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Custers J; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Grazia Pau M; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Schuitemaker H; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
  • Zahn R; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
PLoS One ; 13(2): e0192312, 2018.
Article em En | MEDLINE | ID: mdl-29462200
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Doença pelo Vírus Ebola / Ebolavirus / Marburgvirus / Doença do Vírus de Marburg Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Doença pelo Vírus Ebola / Ebolavirus / Marburgvirus / Doença do Vírus de Marburg Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos